Business:
Targeted Alpha Therapeutics for chemo-resistant Cancers
Drug notes:
https://fusionpharma.com/fusion-pipeline/
About:
Fusion Pharmaceuticals is developing next-generation radiopharmaceuticals as an alternative cancer therapy. Alpha particles are a type of ionizing radiation that induces DNA damage and can be used to kill cells. Fusion arms targeting molecules, like antibodies, with potent alpha emitting medical isotopes to precisely and effectively induce cancer cell death. Alpha particles are useful here since they only travel a short distance, localizing the radiation to the tumor. However, Fusion is also using their proprietary Fast-ClearTM linker technology to promote the rapid clearance of medical isotopes not specifically bound to cancer to create safer therapeutics. Fusion is leveraging their technology to advance a pipeline of alpha-based therapeutic programs to treat various cancers.
In Vivo Scientist Hamilton, ON, CA|6 days ago
Production Operator Hamilton, ON, CA|10 days ago
Scientist III/Senior Scientist, Biology, Group Lea... Hamilton, ON, CA|21 days ago
Sr. Scientist, PK/PD/PMX Boston, MA, US|44 days ago
Facilities Technician Hamilton, Hamilton, ON, CA|52 days ago
Supply Chain Specialist Hamilton, ON, CA|58 days ago
Senior QMS Specialist Boston, Boston, MA, US|80 days ago
Auditor, GCP/GLP/Quality Assurance Boston, Boston, MA, US|100+ days ago
Manager, Batch Release Hamilton, Hamilton, ON, CA|100+ days ago
Associate Director, Preclinical & Translation Phar... Boston, Boston, MA, US|100+ days ago
Manager, Competitive Intelligence Hamilton, ON, CA|100+ days ago